Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
ConditionSeroma Following Procedure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorOmphis Foundation
About this trial
Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.
Eligibility criteria
Qualifiers
Over 18 years old
Conservative surgery for breast cancer with associated axillary lymphadenectomy
Disqualifiers
Mastectomy
History of axillary surgery or ipsilateral axillary radiotherapy
ASA 4 patients. (ASA 3 patients selected)
Lack of adequate cognitive capacity and/or signed informed consent
Trial design
Treatments tested in this trial
- Glubran 2
Treatment groups
134 Participants
are divided into 2 treatment groupsSponsors and collaborators
Omphis Foundation
Lead sponsor
Consorci Sanitari del Maresme
Collaborator
Source ClinicalTrials.gov